- Home
- Companies
- Vigilant Biosciences, Inc.
- Products
- Digital Platform Brings Technology
Digital Platform Brings Technology
Vigilant Biosciences® product is based on advanced patented technology, including an innovative methodology for assessing multiple biomarkers that, together with other clinical factors, can aid clinicians in the early detection of oral cancer. The clinically validated† test contributes to early and accurate† detection of oral cancer, potentially even before visual or physical indicators.
Vigilant Biosciences® digital platform brings technology and early oral cancer detection testing together. The integrated management system assists clinicians in managing patient test data and reporting over time. Clinicians can now easily identify patients that may be high risk to have, or develop, oral cancer at the earliest possible time and refer these patients to a specialist for appropriate treatment.